Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate
about
Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusionCharacterization of a Structural Intermediate of Flavivirus Membrane FusionStructures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common ThemeReceptor Binding and Low pH Coactivate Oncogenic Retrovirus Envelope-Mediated FusionFusion of Enveloped Viruses in Endosomes.Receptor-induced thiolate couples Env activation to retrovirus fusion and infectionVisualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography.Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency.Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.Imaging individual retroviral fusion events: from hemifusion to pore formation and growth.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entryInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virusNa+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.Inhibition of hendra virus fusion.Chemical and Structural Aspects of Ebola Virus Entry Inhibitors.Quantitative imaging of endosome acidification and single retrovirus fusion with distinct pools of early endosomesHeptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathwayStabilization of TM trimer interactions during activation of moloney murine leukemia virus Env.Kinetic dependence of paramyxovirus entry inhibition.Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm.pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation.Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.The six-helix bundle of human immunodeficiency virus Env controls pore formation and enlargement and is initiated at residues proximal to the hairpin turnRetroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry.The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.Conserved leucines in N-terminal heptad repeat HR1 of envelope fusion protein F of group II nucleopolyhedroviruses are important for correct processing and essential for fusogenicity.
P2860
Q27312399-7CB6930A-A787-4ADD-90AA-1AD76FE181E3Q27478061-DE5D72CF-07A1-4794-A46E-4FD2E2685F39Q27487974-7F25DA48-BC1E-46CE-89E1-00B67141FF20Q27490307-C2CB417E-5926-4365-94C1-7F6A367013E3Q28073406-87B0437A-41FF-40A9-B9E2-56BA2F41B14DQ28471846-04078454-2415-41E4-A88B-B0ED8B8E6FC3Q30419638-D8C47419-0401-4E93-AA72-BEE6BAAC6C77Q30434014-2606A2A4-DAD9-47EB-B328-CAE5DDFB104BQ30436957-FCFB0951-65BE-4BFC-832F-00C86CD61FACQ30441449-D64966A5-1BC5-4A9C-92F1-DA800E22D202Q30448472-16F561BD-31A1-4099-A8C4-AA9C7A7E0E0AQ30475969-823CD77F-F15B-4136-898C-C2DA0E8D198FQ30671100-AE46E8CD-DE88-452E-9D80-3A9EC7C3F276Q33741962-B86A1843-2376-4D60-A191-7CF87D712919Q33920306-747085CE-8C00-4A83-9345-EC156EFE8944Q34124095-989A2459-F371-4553-8980-D9A3B9916A9CQ34600362-8490EF83-0D48-4AE0-A77F-345AB87E391DQ34963154-5F8788A6-67B0-455E-B295-FC3B3FA3A18DQ35101317-323EEA66-8C7A-40BD-8ACE-B387F970D8F9Q35589926-ABBC2083-0390-4258-A1A2-9C72B14F348DQ36378462-CC3DA00C-B61D-486A-8EC1-DBD27ECA9A1BQ36424025-28624046-B838-40CF-A694-7361864C36FAQ36483979-20D4304E-487B-4986-A94C-539064DA2977Q37232863-1E742BD2-9BE4-42B2-9A96-EE8229B4B38AQ37348882-5BD897E9-2B45-4153-8EBA-0A181C366931Q38710609-20ACB834-7725-4922-BAE4-32FC2B662BF4Q38761263-82797C53-DC67-4571-B1AE-8DCB5EFF0314Q39462591-0E906DA0-705B-4CB0-BDF9-C7AB03885F26Q39822146-C286BAFB-847A-4E93-9490-DB93BE522204Q40162632-D7F2D420-AAA3-4F1A-A3A7-FD869291BA54Q40179783-C604B6D9-E18D-4DAF-AA4B-05524CCB1D7EQ40340446-6C25799B-0899-4F67-8323-D2AC5627906EQ41902866-FA713300-D284-4FA8-9675-F7F1C75DEAF4
P2860
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@ast
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@en
type
label
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@ast
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@en
prefLabel
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@ast
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@en
P2093
P2860
P1433
P1476
Heptad repeat 2-based peptides ...... identify a fusion intermediate
@en
P2093
Arwen Vermeulen
John W Balliet
Judith M White
Laurie J Earp
Mark J Biscone
Robert C Netter
Sean M Amberg
P2860
P304
13430-13439
P356
10.1128/JVI.78.24.13430-13439.2004
P50
P577
2004-12-01T00:00:00Z